Evidence map›Paper›PMID 33480966›Full record

ArticleJAMA pediatrics2021

Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.

Burkhard Tönshoff, Barbara Müller, Roland Elling, Hanna Renk, Peter Meissner, Hartmut Hengel, Sven F Garbade, Meinhard Kieser, Kathrin Jeltsch, Jürgen Grulich-Henn and 35 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in JAMA pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 2 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 2 syntheses or guidelines pooled it, 148 citations in OpenAlex.

  1. SARS-CoV-2 Circulation in the School Setting: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2022
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Long-Term Antibody Response to SARS-CoV-2 in Children.Journal of clinical immunology · 2023
    Article
  18. Article
  19. Limited role of children in transmission of SARS-CoV-2 virus in households-Immunological analysis of 26 familial clusters.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2023
    Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

45 authors at 8 institutions in 1 country.

Burkhard TönshoffDepartment of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
Barbara MüllerDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
Roland EllingCenter for Pediatrics and Adolescent Medicine, University Medical Centre and Faculty of Medicine Freiburg, Freiburg im Breisgau, Germany.
Hanna RenkUniversity Children's Hospital Tübingen, Tübingen, Germany.
Peter MeissnerDepartment of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
Hartmut HengelInstitute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Sven F GarbadeDepartment of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
Meinhard KieserInstitute for Medical Biometry and Informatics, Ruprecht-Karls University Heidelberg, Heidelberg, Germany.
Kathrin JeltschDepartment of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
Jürgen Grulich-HennDepartment of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
Julia EulerDepartment of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
Maximilian StichDepartment of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
Kristine Chobanyan-JürgensDepartment of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
Maria ZernickelDepartment of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
Aleš JandaDepartment of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
Lena WölfleDepartment of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
Thomas StammingerInstitute of Virology, University of Ulm, Ulm, Germany.
Thomas IftnerInstitute for Medical Virology, University Hospital of Tübingen, Tübingen, Germany.
Tina GanzenmuellerInstitute for Medical Virology, University Hospital of Tübingen, Tübingen, Germany.
Christian SchmittCenter for Pediatrics and Adolescent Medicine, University Medical Centre and Faculty of Medicine Freiburg, Freiburg im Breisgau, Germany.
Tessa GörneCenter for Pediatrics and Adolescent Medicine, University Medical Centre and Faculty of Medicine Freiburg, Freiburg im Breisgau, Germany.
Vibor LaketaDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
Sylvia OlbergDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
Anna PlaszczycaDepartment of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
Mirko CorteseDepartment of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
Ralf BartenschlagerDepartment of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
Constantin PapeHeidelberg Collaboratory for Image Processing, Interdisciplinary Centre for Scientific Computing, Heidelberg University, Heidelberg, Germany.
Roman RemmeHeidelberg Collaboratory for Image Processing, Interdisciplinary Centre for Scientific Computing, Heidelberg University, Heidelberg, Germany.
Daniela HuzlyInstitute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Marcus PanningInstitute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Sebastian WeigangInstitute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Sebastian GieseInstitute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Kevin CiminskiInstitute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Jakob AnkerholdInstitute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Georg KochsInstitute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Martin SchwemmleInstitute of Virology, University Medical Centre and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Rupert HandgretingerUniversity Children's Hospital Tübingen, Tübingen, Germany.
Charlotte M NiemeyerCenter for Pediatrics and Adolescent Medicine, University Medical Centre and Faculty of Medicine Freiburg, Freiburg im Breisgau, Germany.
Corinna EngelCentre for Paediatric Clinical Studies at the University Children's Hospital Tübingen, Tübingen, Germany.
Winfried V KernDepartment of Medicine II, Division of Infectious Diseases and Travel Medicine, University Medical Centre Freiburg, Freiburg, Germany.
Georg Friedrich HoffmannDepartment of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
Axel R FranzCentre for Paediatric Clinical Studies at the University Children's Hospital Tübingen, Tübingen, Germany.
Philipp HennekeCenter for Pediatrics and Adolescent Medicine, University Medical Centre and Faculty of Medicine Freiburg, Freiburg im Breisgau, Germany.
Klaus-Michael DebatinDepartment of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany.
Hans-Georg KräusslichDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
Heidelberg University · DEUniversity of Freiburg · DEUniversität Ulm · DEUniversity Medical Center Freiburg · DEUniversity Children's Hospital Tübingen · DEUniversity Hospital Heidelberg · DEEuropean Molecular Biology Laboratory · DEZimmer Biomet (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: School and daycare closures were enforced as measures to confine the novel coronavirus disease 2019 (COVID-19) pandemic, based on the assumption that young children may play a key role in severe acute respiratory coronavirus 2 (SARS-CoV-2) spread. Given the grave consequences of contact restrictions for children, a better understanding of their contribution to the COVID-19 pandemic is of great importance. Objective: To describe the rate of SARS-CoV-2 infections and the seroprevalence of SARS-CoV-2 antibodies in children aged 1 to 10 years, compared with a corresponding parent of each child, in a population-based sample. Design, Setting, and Participants: This large-scale, multicenter, cross-sectional investigation (the COVID-19 BaWü study) enrolled children aged 1 to 10 years and a corresponding parent between April 22 and May 15, 2020, in southwest Germany. Exposures: Potential exposure to SARS-CoV-2. Main Outcomes and Measures: The main outcomes were infection and seroprevalence of SARS-CoV-2. Participants were tested for SARS-CoV-2 RNA from nasopharyngeal swabs by reverse transcription-polymerase chain reaction and SARS-CoV-2 specific IgG antibodies in serum by enzyme-linked immunosorbent assays and immunofluorescence tests. Discordant results were clarified by electrochemiluminescence immunoassays, a second enzyme-linked immunosorbent assay, or an in-house Luminex-based assay. Results: This study included 4964 participants: 2482 children (median age, 6 [range, 1-10] years; 1265 boys [51.0%]) and 2482 parents (median age, 40 [range, 23-66] years; 615 men [24.8%]). Two participants (0.04%) tested positive for SARS-CoV-2 RNA. The estimated SARS-CoV-2 seroprevalence was low in parents (1.8% [95% CI, 1.2-2.4%]) and 3-fold lower in children (0.6% [95% CI, 0.3-1.0%]). Among 56 families with at least 1 child or parent with seropositivity, the combination of a parent with seropositivity and a corresponding child with seronegativity was 4.3 (95% CI, 1.19-15.52) times higher than the combination of a parent who was seronegative and a corresponding child with seropositivity. We observed virus-neutralizing activity for 66 of 70 IgG-positive serum samples (94.3%). Conclusions and Relevance: In this cross-sectional study, the spread of SARS-CoV-2 infection during a period of lockdown in southwest Germany was particularly low in children aged 1 to 10 years. Accordingly, it is unlikely that children have boosted the pandemic. This SARS-CoV-2 prevalence study, which appears to be the largest focusing on children, is instructive for how ad hoc mass testing provides the basis for rational political decision-making in a pandemic.

Indexed as

AdultAgedAge DistributionAge FactorsAntibodies, ViralChildChild, PreschoolCOVID-19COVID-19 Serological TestingCross-Sectional StudiesGermanyHumansImmunoglobulin AImmunoglobulin GImmunoglobulin MMaleAntibodies, ViralImmunoglobulin AImmunoglobulin GImmunoglobulin M

Identifiers

PMID33480966
PMCPMC7823424
OpenAlexW3125727696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.